<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - QUINOLONES</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drugClass/">Drug classes</a></li>
      </ul>

      <h1>QUINOLONES</h1>

      <nav>
        <ul class="nav nav-list">

          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#importantSafetyInformation" data-toggle="tab">Important safety information</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#allergyAndCrossSensitivity" data-toggle="tab">Allergy and cross sensitivity</a></li>
          <li><a href="#drugsInClass" data-toggle="tab">Drugs in class</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use or <ph outputclass="route">oral</ph> use</h3>
              <p>Avoid in pregnancy&#8212;shown to cause arthropathy in <i>animal</i> studies; safer alternatives are available.</p>
            </section>
      </section>



      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

        
          <h3>Specific side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> diarrhoea, dizziness, headache, nausea, vomiting, diarrhoea, dizziness, headache, nausea, vomiting,
              </p>
              <p>
                <strong>uncommon:</strong> abdominal pain, anorexia, anxiety, arthralgia, asthenia, blood disorders, confusion, depression, disturbances in taste, disturbances in vision, dyspepsia, eosinophilia, hallucinations, leucopenia, myalgia, rash, sleep disturbances, thrombocytopenia, tremor, abdominal pain, anorexia, anxiety, arthralgia, asthenia, blood disorders, confusion, depression, disturbances in taste, disturbances in vision, dyspepsia, eosinophilia, hallucinations, leucopenia, myalgia, rash, sleep disturbances, thrombocytopenia, tremor,
              </p>
              <p>
                <strong>rare:</strong> antibiotic-associated colitis, convulsions, disturbances in hearing, disturbances in smell, dyspnoea, hepatic dysfunction, hepatitis, hypotension, interstitial nephritis, jaundice, photosensitivity, psychoses, renal failure, symptoms of peripheral neuropathy (sometimes irreversible), tendon damage, tendon inflammation, vasculitis, antibiotic-associated colitis, convulsions, disturbances in hearing, disturbances in smell, dyspnoea, hepatic dysfunction, hepatitis, hypotension, interstitial nephritis, jaundice, photosensitivity, psychoses, renal failure, symptoms of peripheral neuropathy (sometimes irreversible), tendon damage, tendon inflammation, vasculitis,
              </p>
              <p>
                <strong>veryRare:</strong> Stevens-Johnson syndrome, toxic epidermal necrolysis, Stevens-Johnson syndrome, toxic epidermal necrolysis,
              </p>
        
            <section class="advice">
              <p>The drug should be <b>discontinued</b> if psychiatric, neurological, or hypersensitivity reactions (including severe rash) occur.</p>
            </section>
        
      </section>




      <section class="tab-pane" id="importantSafetyInformation">
        <h2>Important safety information</h2>

            <section class="importantSafetyInformation">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use or <ph outputclass="route">oral</ph> use</h3>
              <p>The CSM has warned that quinolones may induce <b>convulsions</b> in patients with or without a history of convulsions; taking NSAIDs at the same time may also induce them.</p>
            </section>
            <section class="importantSafetyInformation">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use or <ph outputclass="route">oral</ph> use</h3>
                <p class="title">Tendon damage</p>
              <p>Tendon damage (including rupture) has been reported rarely in patients receiving quinolones. Tendon rupture may occur within 48 hours of starting treatment; cases have also been reported several months after stopping a quinolone. Healthcare professionals are reminded that:</p><ul>
            <li>quinolones are contra-indicated in patients with a history of tendon disorders related to quinolone use;</li>
            <li>patients over 60 years of age are more prone to tendon damage;</li>
            <li>the risk of tendon damage is increased by the concomitant use of corticosteroids;</li>
            <li>if tendinitis is suspected, the quinolone should be discontinued immediately.</li>
            </ul>
            </section>
      </section>

      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
              <strong>With intravenous use:</strong>
            can prolong the QT interval
          </li>
          <li>
              <strong>With intravenous use:</strong>
            conditions that predispose to seizures
          </li>
          <li>
              <strong>With intravenous use:</strong>
            exposure to excessive sunlight should be avoided (discontinue if photosensitivity occurs)
          </li>
          <li>
              <strong>With intravenous use:</strong>
            G6PD deficiency
          </li>
          <li>
              <strong>With intravenous use:</strong>
            history of epilepsy
          </li>
          <li>
              <strong>With intravenous use:</strong>
            myasthenia gravis (risk of exacerbation)
          </li>
          <li>
              <strong>With oral use:</strong>
            can prolong the QT interval
          </li>
          <li>
              <strong>With oral use:</strong>
            conditions that predispose to seizures
          </li>
          <li>
              <strong>With oral use:</strong>
            exposure to excessive sunlight should be avoided (discontinue if photosensitivity occurs)
          </li>
          <li>
              <strong>With oral use:</strong>
            G6PD deficiency
          </li>
          <li>
              <strong>With oral use:</strong>
            history of epilepsy
          </li>
          <li>
              <strong>With oral use:</strong>
            myasthenia gravis (risk of exacerbation)
          </li>
        </ul>
      </section>












      <section class="tab-pane" id="allergyAndCrossSensitivity">
        <h2>Advice regarding allergies and cross sensitivities</h2>

            <section class="contraindications">
              <p>Use of quinolones contraindicated in quinolone hypersensitivity.</p>
            </section>
        
      </section>

      <section class="tab-pane" id="drugsInClass">
        <h2>Drugs in the class of QUINOLONES</h2>

          <ul>
            <li><a href="../drug/PHP3665.html">CIPROFLOXACIN</a></li>
            <li><a href="../drug/PHP3668.html">LEVOFLOXACIN</a></li>
            <li><a href="../drug/PHP3671.html">MOXIFLOXACIN</a></li>
            <li><a href="../drug/PHP3673.html">NALIDIXIC ACID</a></li>
            <li><a href="../drug/PHP3675.html">NORFLOXACIN</a></li>
            <li><a href="../drug/PHP3678.html">OFLOXACIN</a></li>
          </ul>
      </section>

    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
</body>
</html>
